ELOX 10-Q: SEC filing

Eloxx Pharmaceuticals

Filed with the SEC on · accession 0001193125-26-461189

ELOX filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -3.0% by the first close after the filing.

Summary of the filing

Eloxx Pharmaceuticals filed its Q3 2026 10-Q, reporting continued losses and a going concern situation with negative stockholders' equity, offset by various equity financings including pre-funded warrants and a securities purchase agreement.

Key details

FilerEloxx Pharmaceuticals, Inc.
Securities purchase agreement counterpartyCoastlands
LenderDomicilium
LenderHercules
License agreement counterpartyAlmirall
Agreement counterpartyCystic Fibrosis Foundation
Research agreement counterpartyTechnion Research and Development Foundation Ltd
Research arrangement counterpartyIsrael Innovation Authority

How ELOX stock reacted

Close before

$13.15

Nov 13, 2026

First close after

-3.04%

$12.75

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ELOX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ELOX?

Click here

Frequently asked questions

What did ELOX file with the SEC on Nov 16, 2026?

ELOX filed a 10-Q (SEC filing). Eloxx Pharmaceuticals filed its Q3 2026 10-Q, reporting continued losses and a going concern situation with negative stockholders' equity, offset by various equity financings including pre-funded warrants and a securities purchase agreement.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ELOX stock react to this filing?

ELOX closed at $13.15 before the filing and $12.75 on Nov 16, 2026 (-3.04%).

Other ELOX SEC filings

Get alerts when ELOX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days